VINCI CAPITAL
16
14M
11
0.80
3
0.31
7
- Stages of investment
- Areas of investment
Summary
In 2003 was created VINCI CAPITAL, which is appeared as VC. The fund was located in Europe if to be more exact in Switzerland. The main office of represented VC is situated in the Lausanne.
We also calculated 6 valuable employees in our database.
Among the most popular fund investment industries, there are Software, Food and Beverage. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland. The fund has exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Addex Therapeutics, Anergis, Beqom
The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually. This VINCI CAPITAL works on 11 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2009. Speaking about the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the VINCI CAPITAL, startups are often financed by Novartis Venture Fund, Dansk Innovation, BioMedPartners. The meaningful sponsors for the fund in investment in the same round are Wellington Partners, Swisscom Ventures, BioMedPartners. In the next rounds fund is usually obtained by Wellington Partners, Swisscom Ventures, Renaissance PME Foundation.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 3
- Exits
- 7
- Rounds per year
- 0.80
- Follow on index
- 0.31
- Investments by industry
- Health Care (11)
- Biotechnology (10)
- Medical (9)
- Personal Health (4)
- Consulting (4) Show 20 more
- Investments by region
-
- Switzerland (15)
- Germany (1)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 39M
- Group Appearance index
- 1.00
- Avg. company exit year
- 20
- Avg. multiplicator
- 4.47
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Evolva | 11 Dec 2009 | Biotechnology, Food and Beverage, Health Care, Wellness, Consulting | Early Stage Venture | 17M | Switzerland, Aargau |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.